--- https://www.santepubliquefrance.fr/docs/survie-des-personnes-atteintes-de-cancer-en-france-metropolitaine-1989-2018-syndrome-myelodysplasique 2021 France technical report neoplasm, malignant France myelodysplasia france neoplasms Myelodysplastic syndrome persons France France french myelodysplastic syndromes France survival disease cancer
--- https://www.santepubliquefrance.fr/docs/survie-des-personnes-atteintes-de-cancer-en-france-metropolitaine-1989-2018-leucemie-myelomonocytaire-chronique-et-autres-syndromes-myelodysplasi 2021 France technical report neoplasms France myelodysplasia survival myelodysplastic syndromes persons neoplasm, malignant leukaemia france Chronic myelomonocytic leukemia France France leukemia, myelomonocytic, chronic cancer disease France french myeloproliferative disorders
--- https://www.medg.fr/syndrome-myelodysplasique-smd 2019 France teaching material scientific and technical information myelodysplastic syndromes Myelodysplastic syndrome myelodysplasia
--- https://pgtmsite.files.wordpress.com/2024/01/5-azacitidine_ad_version-finale_site-public_20151112.pdf 2015 Canada drug information Gleason Grade Group 5 Thought Score 5 Agreement Score 5 Phase V Trial Death Related to Adverse Event Use Severity of Symptom Score 5 myelodysplasia Illness Intrusiveness Rating 5 Loss of Chromosome 5 Intensity and Distress 5 myelodysplastic syndromes NCI CTEP SDC Myelodysplastic Syndrome Sub-Category Terminology Analyzed Analysis Adult Myelodysplastic Syndrome Clinical Status Ordinal Scale Outcome 5 Fear Score 5 Childhood Myelodysplastic Syndrome Identifier Description azacitidine Azacitidine ECOG Performance Status 5 Current Reformed Smoker, Years Unknown Neck Pain Score 5 Upset Score 5
--- https://pgtmsite.files.wordpress.com/2024/01/azacitidine_es_20120430.pdf 2012 Canada drug information myelodysplastic syndromes leukaemia Adult Acute Myeloid Leukemia Treat Childhood Myelodysplastic Syndrome During Treatment Myelodysplastic Syndrome Acute Myeloid Leukemia Childhood Acute Myeloid Leukemia Treatment Study Therapy Object NCI CTEP SDC Myelodysplastic Syndrome Sub-Category Terminology Biomaterial Treatment Adult Myelodysplastic Syndrome AML Lab Table Treatment Epoch NCI CTEP SDC Acute Myeloid Leukemia Sub-Category Terminology Azacitidine leukemia, myeloid, acute Acute Myeloid Leukemia without Maturation On Treatment GDC Treatment Frequency Terminology Acute Myeloid Leukemia with KMT2A Rearrangement azacitidine Treatment No Treatment for Diabetes Acute Myeloid Leukemia Pathway myelodysplasia